Sg3 Management, LLC Esperion Therapeutics, Inc. Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $30,540 - $51,000	6,000 New	6,000 $37,000
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $45,360 - $85,480	-4,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $77,600 - $114,840	4,000 New	4,000 $85,000
Q3 2020 Nov 13, 2020	SELL	$31.18 - $52.71 $77,950 - $131,775	-2,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $285,380 - $487,445	-9,500 Reduced 79.17%	2,500 $128,000
Q1 2020 May 12, 2020	BUY	$27.44 - $73.84 $329,280 - $886,080	12,000 New	12,000 $378,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.